| First Author | Boutin AT | Year | 2017 |
| Journal | Genes Dev | Volume | 31 |
| Issue | 4 | Pages | 370-382 |
| PubMed ID | 28289141 | Mgi Jnum | J:242160 |
| Mgi Id | MGI:5904560 | Doi | 10.1101/gad.293449.116 |
| Citation | Boutin AT, et al. (2017) Oncogenic Kras drives invasion and maintains metastases in colorectal cancer. Genes Dev 31(4):370-382 |
| abstractText | Human colorectal cancer (CRC) is a major cause of cancer mortality and frequently harbors activating mutations in the KRAS gene. To understand the role of oncogenic KRAS in CRC, we engineered a mouse model of metastatic CRC that harbors an inducible oncogenic Kras allele (Krasmut ) and conditional null alleles of Apc and Trp53 (iKAP). The iKAP model recapitulates tumor progression from adenoma through metastases. Whole-exome sequencing revealed that the Krasmut allele was heterogenous in primary tumors yet homogenous in metastases, a pattern consistent with activated Krasmut signaling being a driver of progression to metastasis. System-level and functional analyses revealed the TGF-beta pathway as a key mediator of Krasmut -driven invasiveness. Genetic extinction of Krasmut resulted in specific elimination of the Krasmut subpopulation in primary and metastatic tumors, leading to apoptotic elimination of advanced invasive and metastatic disease. This faithful CRC model provides genetic evidence that Krasmut drives CRC invasion and maintenance of metastases. |
